Bafna Pharmaceuticals Limited (BAFNAPH) — Capital Reinvestment Ratio
Bafna Pharmaceuticals Limited (BAFNAPH) has a Capital Reinvestment Ratio of 1.76x as of September 2025, meaning it reinvests 2% of its operating cash flow (Rs93.12 Million) in capital expenditures (Rs164.17 Million). Check Bafna Pharmaceuticals Limited tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bafna Pharmaceuticals Limited Capital Reinvestment Ratio (2007–2026)
This chart tracks Bafna Pharmaceuticals Limited's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Bafna Pharmaceuticals Limited generate cash.
Annual Capital Reinvestment Ratio for Bafna Pharmaceuticals Limited (2007–2026)
Year-by-year Capital Reinvestment Ratio for Bafna Pharmaceuticals Limited from 2007 to 2026. See Bafna Pharmaceuticals Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 2.11x | Rs118.27 Million | Rs249.03 Million | ▲ +88.1% |
| 2025 | 1.12x | Rs195.29 Million | Rs218.60 Million | ▼ -31.8% |
| 2024 | 1.64x | Rs94.85 Million | Rs155.78 Million | ▼ -1.0% |
| 2023 | 1.66x | Rs49.52 Million | Rs82.19 Million | ▲ +114.1% |
| 2022 | 0.78x | Rs97.28 Million | Rs75.41 Million | ▼ -69.4% |
| 2016 | 2.53x | Rs9.11 Million | Rs23.07 Million | ▲ +246.7% |
| 2015 | 0.73x | Rs106.65 Million | Rs77.90 Million | ▼ -33.1% |
| 2014 | 1.09x | Rs16.06 Million | Rs17.53 Million | ▲ +1778.7% |
| 2013 | 0.06x | Rs366.32 Million | Rs21.28 Million | ▼ -96.9% |
| 2007 | 1.85x | Rs101.06 Million | Rs187.01 Million | — |